Overview

A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

Status:
Recruiting
Trial end date:
2023-02-02
Target enrollment:
Participant gender:
Summary
A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients with High TG and Low HDL-C
Phase:
Phase 3
Details
Lead Sponsor:
Kowa Company, Ltd.
Treatments:
Fenofibrate